Online Office
Download CenterMore...
LinksMore...
WeChat
WeChat Code
Website Code
Subscribe Code

Most Downloaded

Published in last 1 year | In last 2 years| In last 3 years| All| Most Downloaded in Recent Month| Most Downloaded in Recent Year|

Most Downloaded in Recent Month
Please wait a minute...
For Selected: Toggle Thumbnails
Guidelines for the prevention and treatment of metabolic dysfunction-associated (non-alcoholic) fatty liver disease(Version 2024)
Chinese Society of Hepatology, Chinese Medical Association
Journal of Practical Hepatology    2024, 27 (4): 494-510.  
Abstract (5188)      PDF(pc) (3936KB)(4468)      
The Chinese Society of Hepatology of the Chinese Medical Association invited relevantexperts to revise and update the Guideline of Prevention and Treatment of Nonalcoholic Fatty Liver Disease(2018Version) and renamed it as (Version 2024) Guideline for the Prevention and Treatment of MetabolicDysfunction-associated (non-alcoholic) Fatty Liver Disease. Herein, the guiding recommendations on clinicalissues such as screening and monitoring, diagnosis and evaluation, treatment and follow-up of metabolicdysfunction-associated fatty liver disease are put forward.
Reference | Related Articles | Metrics
Diagnosis and treatment of patients with hemophagocytic syndrome
Li Wencong, Zhang Xiaoxiao, Nan Yuemin
Journal of Practical Hepatology    2022, 25 (5): 612-615.   DOI: 10.3969/j.issn.1672-5069.2022.05.002
Abstract (460)      PDF(pc) (817KB)(8326)      
Reference | Related Articles | Metrics
Portal hypertension: indication of transjugular intrahepatic portosystemic shunt and the prevention of related complications
Lai Ruimin, Zhu Yuejiu
Journal of Practical Hepatology    2023, 26 (1): 4-7.   DOI: 10.3969/j.issn.1672-5069.2023.01.002
Abstract (297)      PDF(pc) (846KB)(3447)      
Reference | Related Articles | Metrics
Polyene phosphatidylcholine and compound glycyrrhizin combination in the treatment of patients with drug-induced liver injury
Xu Guobin, Hai Hua, Sun Hongfei, et al
Journal of Practical Hepatology    2026, 29 (4): 553-556.   DOI: 10.3969/j.issn.1672-5069.2026.04.019
Abstract (179)      PDF(pc) (876KB)(1274)      
Objective The aim of this study was to investigate the clinical efficacy of polyene phosphatidylcholine in combination with compound glycyrrhizin in the treatment of patients with drug-induced liver injury (DILI). Methods 122 patients with DILI were encountered in our hospital between January 2023 and December 2024, and were randomly assigned to receive intravenous polyene phosphatidylcholine in control (n=61), or receive intravenous polyene phosphatidylcholine and compound glycyrrhizin combination in observation (n=61) for two to six weeks. Serum superoxide dismutase (SOD) level was measured by radioimmunoassay, serum malondialdehyde (MDA) level was determined by biochemical colorimetry and serum glutathione peroxidase (GSH-Px) level was detected by velocity method. Serum interleukin (IL)-6, IL-1β and tumor necrosis factor-α (TNF-α) levels were measured by ELISA. Cost/efficacy was calculated by medicine cost/effectiveness. Results By end of average four-week treatment, serum ALT, AST and ALP levels in the observation group were (56.2±9.3)U/L, (46.3±9.8)U/L and (90.6±10.2)U/L, all much lower than [(69.1±10.7)U/L, (59.5±10.2)U/L and (109.3±11.3)U/L, respectively, P<0.05] in the control; serum SOD and GSH-Px levels were (95.1±10.4)U/mL and (119.7±13.1)μmol/L, both significantly higher than [(73.4±9.2)U/mL and (95.3±11.9)μmol/L, respectively, P<0.05], while serum MDA level was (2.7±0.6)μmol/L, significantly lower than [(3.8±0.7)μmol/L, P<0.05] in the control; serum IL-6, IL-1β and TNF-α levels were (7.2±1.6)pg/mL, (16.5±3.1)ng/mL and (7.5±1.8)pg/mL, all significantly lower than [(9.8±1.9)pg/mL, (22.4±4.0)ng/mL and (11.3±2.1)pg/mL, respectively, P<0.05] in the control group; medical cost in the observation group was higher than in the control, but the treatment effectiveness rate was 98.4%, much higher than 59.0%(P<0.05) in the control group. Conclusion Combination of polyene phosphatidylcholine and compound glycyrrhizin in dealing with patients with DILI could get a satisfactory effectiveness, which might be related to inhibition of oxidative stress and cytokine reactions.
Reference | Related Articles | Metrics
Diagnostic efficacy of endoscopic ultrasonography for sludge-like stones in the common bile ducts: Comparison with abdominal ultrasonography, CT and MRCP
He Ting, Chen Xufeng, Zhou Jianfei, et al
Journal of Practical Hepatology    2026, 29 (4): 621-624.   DOI: 10.3969/j.issn.1672-5069.2026.04.036
Abstract (139)      PDF(pc) (875KB)(815)      
Objective The aim of this study was to investigate diagnostic performance of endoscopic ultrasonography (EUS) in comparison with abdominal ultrasonography (US), computed tomography (CT) and magnetic resonance cholangiopancreatography (MRCP) in detecting sludge-like stones in the common bile duct. Methods 67 patients with sludge-like stones and 70 patients with formed stones were encountered in our hospital between August 2022 and June 2025, and all underwent EUS, US, CT and MRCP, and endoscopic retrograde cholangiopancreatography (ERCP) or surgical removal of stones. Results Of 67 patients with sludge-like common bile duct stones proven by EUS, stones presented as diffuse punctate hyperechoic spots in 59 cases (88.1%), blurred bile duct walls or focal thickened in 52 cases (77.6%), stratified deposition in 46 cases (68.7%), faint tapering shadow in 41 cases (61.2%) and flocculent floating echoes in 38 cases (56.7%); the AUCs were 0.92, 0.95, 0.97 and 0.99 by US, CT, MRCP and EUS in detecting formed stones, while they were 0.73, 0.78, 0.83 and 0.98 in detecting sludge-like stones,suggesting EUS detection much superior to conventional imaging; of the 67 patients with sludge-like stones proven by EUS, misdiagnosis by US, CT, MRCP occurred in 49 cases (73.1%), and of which, either US, CT or MRCP didn’t find it in 5 cases (7.5%); reasons of missed diagnosis included diameter of stone less than 3 mm, scattered deposition or lack of typical echo, etc. Conclusion EUS holds significant diagnostic value for sludge-like stones in the common bile ducts, particularly when conventional imaging results are negative or atypical. Future studies should further validate the specific signs of sludge-like stones on EUS and explore its role in monitoring and treatment strategy selection, which might provide a more robust evidence for the precise diagnosis and management of biliary diseases.
Reference | Related Articles | Metrics
Liver cirrhosis and infections: the state of the disease
Nan Yuemin, Li Jiazheng
Journal of Practical Hepatology    2022, 25 (5): 609-611.   DOI: 10.3969/j.issn.1672-5069.2022.05.001
Abstract (420)      PDF(pc) (790KB)(2988)      
Reference | Related Articles | Metrics
Expert consensus on the management of diabetes mellitus in patients with liver cirrhosis
Chronic Disease Management Branch, China Pharmaceutical Biotechnology Association
Journal of Practical Hepatology    2022, 25 (5): 0-S1.   DOI: 10.3969/j.issn.1672-5069.2022.05.039
Abstract (590)      PDF(pc) (2789KB)(9056)      
In view of the high prevalence of diabetes mellitus in patients with liver cirrhosis and the increasing trend of non?alcoholic fatty liver disease?associated cirrhosis, the diagnosis and treatment of diabetes mellitus in patients with liver cirrhosis are becoming widespread concerns. Therefore, the Chronic Disease Management Branch, China Pharmaceutical Biotechnology Association, organized multidisciplinary experts from gastroenterology, infective disease, endocrinology, etc, to draw up expert consensus on the management of diabetes mellitus in patients with liver cirrhosis, with focusing on the classification and management of hyperglycemia in cirrhotic patients. The consensus summarizes the prevalence, pathogenesis, clinical setting and prognosis of the concomitant diabetes mellitus in patients with liver cirrhosis, and definitely puts forward a proposal regarding "hepatogenous diabetes" as one of the four subtypes of diabetes mellitus in cirrhotic patients, and further recommends the basic principles for diagnosing and monitoring diabetes mellitus and the selection of antidiabetic drugs based on liver functions in patients with liver cirrhosis.
Reference | Related Articles | Metrics
Guidelines for the diagnosis and treatment of acute-on-chronic liver failure (2025 version)
Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association; Nutrition and Regeneration in End-Stage Liver Disease Group, Chinese Society of Hepatology, Chinese Medical Association
Journal of Practical Hepatology    2025, 28 (5): 641-647.   DOI: 10.3969/j.issn.1672-5069.2025.05.001
Abstract (800)      PDF(pc) (1028KB)(7522)      
Acute-on-chronic liver failure (ACLF) is one of the leading causes of mortality among patients with chronic liver disease. Potentially reversible, ACLF requires precise clinical classification to facilitate accurate diagnosis, targeted treatment, and comprehensive management. Based on the latest research findings and clinical evidence, the Severe Liver Disease and Artificial Liver Group and the Nutrition and Regeneration in End-Stage Liver Disease Group, Chinese Society of Hepatology, Chinese Medical Association, together with multidisciplinary experts, have jointly compiled China's first guideline for the diagnosis and treatment of ACLF. The guideline aims to provide guidance for the diagnosis, treatment, and individualized management of patients with ACLF in clinical practice.
Reference | Related Articles | Metrics
Multi-slice spiral CT features of patients with gallbladder adenomyosis different from with gallbladder cancer
Yang Fan, Wang Jian, Wen Zhi
Journal of Practical Hepatology    2022, 25 (1): 140-143.   DOI: 10.3969/j.issn.1672-5069.2022.01.035
Abstract (941)      PDF(pc) (3720KB)(5410)      
Objective The aim of this study was to summarize the imaging features of multi-slice spiral CT (MSCT) in patients with gallbladder adenomyosis and in patients with gallbladder carcinoma. Methods 113 patients with gallbladder adenomyosis and 78 with gallbladder carcinoma were enrolled in our hospital between September 2015 and September 2020, and all patients underwent MSCT and ultrasonography. The histophthological examination was performed after surgery. Results The consistency of diagnosis by MSCT based on postoperative histopathological examination (Kappa=0.749) was stronger than that by ultrasonography (Kappa=0.577); the accuracy rate by MSCT scan in the diagnosis of patients with gallbladder adenomyosis was higher than that by ultrasonography(88.0% vs. 79.6%, P<0.05); the diagnosis of special, local gallbladder adenomyosis, by MSCT was also higher than that by ultrasonography (97.1% vs. 82.9%, P<0.05); the CT scan showed that the percentages of smooth gallbladder walls, RAS sinus display and clear boundary between liver and gallbladder in patients with gallbladder adenomyosis were 36.3%, 36.3% and 69.0%, all significantly higher than 9.0%, 6.4% and 38.5% in patients with gallbladder carcinoma (P<0.05). Conclusion The diagnostic accuracy of patients with gallbladder adenomyosis by MSCT is relatively high, and its imaging feature might help discriminate gallbladder adenomyosis from cancer.
Reference | Related Articles | Metrics
Non-cirrhotic portal hypertension: current state
Zhao Jianbo, Tan Qing
Journal of Practical Hepatology    2021, 24 (5): 613-616.   DOI: 10.3969/j.issn.1672-5069.2021.05.002
Abstract (369)      PDF(pc) (836KB)(3573)      
Reference | Related Articles | Metrics
Standardization treatment of patients with portal hypertension and gastroesophageal variceal bleeding
Huang Xiaoquan, Chen Shiyao
Journal of Practical Hepatology    2023, 26 (1): 1-3.   DOI: 10.3969/j.issn.1672-5069.2023.01.001
Abstract (462)      PDF(pc) (795KB)(1269)      
Reference | Related Articles | Metrics
Total liver volume/spleen volume ratio by multislice CT calculation in diagnosis of patients with liver cirrhosis
Sun Hao, Zhu Guijuan, Chen Xiaoyu
Journal of Practical Hepatology    2020, 23 (6): 837-840.   DOI: 10.3969/j.issn.1672-5069.2020.06.020
Abstract (375)      PDF(pc) (1071KB)(2853)      
Objective The aim of this study was to investigate the value of total liver volume (TLV)/spleen volume (SV) ratio by multislice CT calculation in diagnosis ofpatients with liver cirrhosis (LC). Methods 138 cirrhotic patients and 130 patients with benign liver diseases or healthy persons were admitted to our hospital between October 2016 and October 2019, and all underwent dynamic contrast-enhanced multi-slice spiral CT scan. The TLV, right liver volume (RV), left inner lobe volume(LMV), left outer lobe volume (LLV), cauda lobe volume (CV), SV as well as TLV/RV ratio, TLV/LMV ratio, TLV/LLV ratio, TLV/CV ratio and TLV/SV ratio were calculated by software. Results The TLV, RV and LMV of liver in patients with LC were (1078.2±315.7) cm3, (543.8±186.5) cm3 and (163.6±73.7) cm3, significantly smaller than [(1470.4±199.7) cm3, (933.3±174.1) cm3 and (216.2±40.1) cm3, respectively, P<0.05], while the LLV and SV were (327.8±121.9) cm3 and (863.4±396.8) cm3, both significantly larger than [(275.9±65.7) cm3 and (256.3±81.7) cm3, respectively,P<0.05] in the control; the TLV / RV ratio in patients with LC was 2.0±0.9, significantly higher than [1.6±0.7, P<0.05], while the TLV / LLV ratio, TLV / CV ratio and TLV / SV ratio were (3.3±1.5), (25.3±12.4) and (1.3±0.6), all significantly lower than [(5.3±2.5),( 32.8±16.1) and (5.7±2.4), respectively, P<0.05] in the control; there were no significant differences in CV and TLV/LMV ratio between the two groups (P>0.05). Conclusion The calculation of TLV/SV by multislice spiral CT scan might help diagnose LC in clinical practice.
Reference | Related Articles | Metrics
Etiology of ascites:what’s going on
Cui Ruibing, Yan Ming.
JOURNAL OF PRACTICAL HEPATOLOGY    2018, 21 (5): 657-660.   DOI: 10.3969/j.issn.1672-5069.2018.05.001
Abstract (395)      PDF(pc) (356KB)(1938)      
Reference | Related Articles | Metrics
New concept of hepatic encephalopathy:from guideline to clinical practice
Chen Dongfeng, Sun Wenjing
JOURNAL OF PRACTICAL HEPATOLOGY    2016, 19 (1): 16-19.   DOI: 10.3969/j.issn.1672-5069.2016.01.005
Abstract (381)      PDF(pc) (477KB)(2591)      
Reference | Related Articles | Metrics
Evaluation of blood supply and hepatic arterial embolization efficacy by CT enhanced scan in patients with hepatic hemangioma
Xu Qianshan, Xu Tong, Jin Lei, et al
Journal of Practical Hepatology    2024, 27 (4): 627-630.   DOI: 10.3969/j.issn.1672-5069.2024.04.034
Abstract (328)      PDF(pc) (1559KB)(2087)      
Objective This study was conducted to evaluate blood supply and hepatic arterial embolization (HAE) efficacy by enhanced computed tomography (CT) in patients with hepatic hemangioma (HH). Methods 127 consecutive patients with HH were encountered in our hospital between December 2017 and January 2021, and all patients underwent CT plain and enhanced scan to measure arterial phase enhancement ratio and evaluate blood supply of HH. All patients were treated with HAE, followed-up for 3 years, and reduction rate of tumor size and arterial phase enhancement rate of HH were compared. Results Of 127 patients with HH, enhanced CT scan found rich blood supply lesions in 54 cases and poor blood supply lesions in 73 cases; of 54 lesions with rich blood supply, uniform enhancement at arterial stage in 18 cases, uneven enhancement in 25 cases, continuously enhanced at venous and delayed stage, and not enhanced at three-stages in 11 cases; enhancement rate at arterial stage in HH lesions with rich blood supply was(43.1±13.6)%, much higher than [(16.5±3.7)%, P<0.05] in lesions with poor blood supply, and percentage of greater than 10 cm lesions was 9.3%, much lower than 64.4%(P<0.05) in lesions with poor blood supply; by two and three years of follow-up, reduction rates of tumors with rich blood supply were(32.6±7.1)% and (53.9±10.2)%, and reduction rates of arterial stage enhancement were (21.8±2.4)% and (27.5±3.1)%, all significantly higher than [(21.5±4.9)% and (34.7±6.9)%, and (14.2±2.5)% and (19.6±2.7)%, P<0.05] in lesions with poor blood supply. Conclusion Efficacy of HAE in dealing with HH with rich blood supply is better than those with poor blood supply, and evaluation of blood supply of HH by CT enhanced scan before operation might help make choice of measures and warrants further investigation.
Reference | Related Articles | Metrics
Risk factors for postoperative stone recurrence after laparoscopic cholecystolithotomy in patients with gallstones
Xia Wei, Cong Miaomiao
Journal of Practical Hepatology    2026, 29 (4): 613-616.   DOI: 10.3969/j.issn.1672-5069.2026.04.034
Abstract (128)      PDF(pc) (873KB)(956)      
Objective This study aimed to investigate risk factors for postoperative stone recurrence after laparoscopic gallbladder-preserving cholecystolithotomy in patients with gallstones. Methods A total of 244 consecutive patients with gallstones were encountered in our hospital between January 2022 and December 2024, and all patients underwent before operation color Doppler ultrasonography to record peak systolic veIocity (PSV), end diastolic velocity (EDV) and mean flow velocity (Vm) of gallbladder artery. All patients underwent laparoscopic cholecystolithotomy, and were followed-up for one year. Multivariate Logistic regression analysis was applied to identify independent risk factors for postoperative stone recurrence. Results The stone recurrence rate was 11.9% (29/244) in our series by end of one-year follow-up after surgery; the gallbladder wall thickness, proportion of stone impaction and EDV level in the stone recurrence group were(2.8±0.4)mm, 13.8% and (10.9±2.2)cm/s, all significantly greater than [(2.4±0.2)mm, 3.7% and (9.2±1.4)cm/s, respectively, P<0.05] in non-recurrence group; multivariate Logistic regression analysis showed that thicken gallbladder wall (OR=14.534,P<0.05), impacted stone (OR=4.656,P<0.05) and increased EDV level(OR=1.329,P<0.05) were all the independent risk factors for stone recurrence. Conclusion Gallstone might recur after laparoscopic cholecystolithotomy in patients with gallbladder stones, and color Doppler ultrasound could be the best postoperative follow-up strategies to find it early.
Reference | Related Articles | Metrics
Short-term efficacy of different statins in treatment of patients with nonalcoholic fatty liver disease and hyperlipidaemia
Pan Fei, Shou Juan, Zhang Dongqing
Journal of Practical Hepatology    2022, 25 (5): 665-668.   DOI: 10.3969/j.issn.1672-5069.2022.05.015
Abstract (510)      PDF(pc) (829KB)(2474)      
Objective The aim of this study was to investigate the short-term efficacy of different statins in treatment of patients with nonalcoholic fatty liver disease (NAFLD) and hyperlipidaemia. Methods 52 patients with NAFLD and hyperlipidaemia were encountered in our hospital between September 2019 and May 2021, and were divided into two groups, with 26 cases in each group, receiving pitavastatin or atorvastatin treatment for six months. The homeostasis model assessment-insulin resistance index (HOMA-IR) were obtained, and serum tumor necrosis factor-α ( TNF-α) , interleukin-6 (IL-6) , IL-8 and high-sensitivity C-reactive protein (hs-CRP) were detected by ELISA. The controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) were recorded by FibroTouch. Results At the end of 6 months of treatment, the HOMA-IR, total cholesterol (TC), triglyceride (TG) and low density lipoprotein cholesterol (LDL- C ) levels in the pitavastatin-treated patients were (2.1±0.5), (3.5±0.4)mmol/L, (2.4±0.3)mmol/L and (2.2±0.5)mmol/L, significantly lower than [(2.5±0.4), (4.2±1.0)mmol/L, (2.9±0.4)mmol/L and (2.9±0.7)mmol/L, respectively, P<0.05], while serum high density lipoprotein cholesterol (HDL-C) level was (1.6±0.4)mmol/L, significantly higher than [(1.3±0.3)mmol/L, P<0.05] in atorvastatin-treated patients; there were no significant differences respect to serum cytokine levels between the two groups(P>0.05); the CAP in the pitavastatin-treated patients was (258.4±6.3)dB/m, much lower than [(267.7±10.2)dB/m, P<0.05] in atorvastatin-treated patients; there was no significant difference as respect to liver parenchymal echo manifestations (P>0.05). Conclusion The statins could alleviate insulin resistance, reduce blood lipid levels and inhibit inflammatory reactions in patients with NAFLD and hyperlipidaemia, and the administration ofpitavastatinseems promising, and warrants further investigation.
Reference | Related Articles | Metrics
Clinical efficacy of hepatic artery chemoembolization in the treatment of patients with primary liver cancer
Xu Dong, Yuan Weidong
JOURNAL OF PRACTICAL HEPATOLOGY    2015, 18 (2): 195-196.   DOI: 10.3969/j.issn.1672-5069.2015.02.024
Abstract (324)      PDF(pc) (651KB)(1202)      
Reference | Related Articles | Metrics
Efficacy of one-step and step-by-steplaparoscopic cholecystectomy in the treatment of patients with gallbladder stones and common bile duct stones
Feng Hao, Lyu Haitao, Wang Ziwei, et al
Journal of Practical Hepatology    2021, 24 (3): 435-438.   DOI: 10.3969/j.issn.1672-5069.2021.03.033
Abstract (408)      PDF(pc) (810KB)(3735)      
Objective The aim of this study was to investigate the efficacy of one-step and step-by-step laparoscopic cholecystectomy (LC) in the treatment of patients with gallbladder stones and common bile duct stones. Methods 152 patients with gallbladder stones and common bile duct stones were admitted to our hospital between January 2016 and June 2019, 87 patients received one-step surgery, e.g., LC and laparoscopic common bile duct exploration (LCBDE), and 65 patients received step-by-step surgery, e.g., endoscopic retrograde cholangiopancreatography/papillary endoscopic sphincterotomy (ERCP/EST) and afterward LC.Results The total surgical time and postoperative catheter placement rate in patients with one-step surgery were (156.3±42.6)min and 98.9%, significantly longer or higher than [(124.4±31.4)min and 15.4%, P<0.05] in patients receiving step-by-step surgery, while the hospital stay and hospitalization cost were (14.4±3.9)d and (27.9±7.0)thousand yuan, significantly shorter or lower than(18.7±4.2)d and(31.24±5.8)thousand yuan (P<0.05) in the latter; there were no statistically significant differences in the surgical success rate and stone clearance rate between the two groups (95.4% vs. 93.1% and 100.0% vs. 96.9%, respectively, P>0.05); the incidence rate of reflux cholangitis in one-step-treated patients was significantly lower than step-by-step surgery-treated patients (0.0% vss 7.7%, P<0.05), while there was no significant difference in the total incidence of complications between the two groups (19.5% vs. 32.1%, P>0.05).Conclusion Both the one-step and step-by-step with patients with gallbladder surgery are efficacious in dealing stones and common bile duct stones, and under some circumstances, the one-step surgery might eradicate the stones rapidly and get a good efficacy.
Reference | Related Articles | Metrics
Micro-122 levels in liver fibrosis in vitro and in vivo
Wang Yan, Li Weijia, Li Ya, et al
Journal of Practical Hepatology    2023, 26 (1): 19-22.   DOI: 10.3969/j.issn.1672-5069.2023.01.006
Abstract (363)      PDF(pc) (1590KB)(2804)      
Objective The purpose of this experiment was to explore the roles of microRNA(miR)-122 in the pathogenesis of liver fibrosis by in vitro and by in vivo. Methods The liver fibrosis model was established in C57BL/6 mice by intraperitoneal injection of carbon tetrachloride and also in HSC-T6 cells in vitro by incubation with 10 ng/ml transforming growth factor-β1 (TGF-β1). The miR-122 agomir and miR-122 mimics were transfected to overexpress miR-122 in mice and in hepatic stellate cells. The total RNA and whole protein were extracted for RT-PCR and Western-blot detection of miR-122, α-smooth muscle actin (α-SMA), type I collagen (Collagen Ⅰ), tissue inhibitor of metalloproteinase 1 (TIMP-1), and platelet-derived growth factor (PDGF). The proliferation of HSC-T6 cells was detected by CCK-8. Results The expression of α-SMA in the liver tissue in the model animal was significantly higher than that in the control group (9.92±2.12 vs. 1.12±0.54, P<0.01), while the miR-122 level was significantly lower than that in the control group (0.95±0.31 vs. 2.07±0.28, P<0.01); in mice with carbon tetrachloride-induced liver fibrosis, the miR-122 level in the miR-122 agomir-transfected group was significantly higher than that in the miR-122 agomir control-transfected group (6.27±1.73 vs. 2.78±0.21, P < 0.01); the α-SMA, type I collagen, TIMP-1 and PDGF protein expression in the miR-122 agomir-transfected group were significantly decreased; in TGF-β1-intervened HST-T6 cells, the α-SMA expression increased as the prolongation of TGF-β1 treatment (0h:0.61±0.02, 12 h:0.69±0.05, 24 h:0.75±0.01, 48 h:1.01±0.03, P<0.05), while the miR-122 levels decreased (0 h:0.72±0.05, 12 h:0.45±0.01, 24 h:0.37±0.03, 48 h:0.29±0.08, P<0.05); the miR-122 level in the miR-122 mimics-transfected cells greatly increased as compared with the miR-122 negative control-transfected cells (178.45±30.62 vs. 12.18±2.39, P<0.01); the Western blot showed that the expression of α-SMA protein was significantly down-regulated in the miR-122 mimics-transfected group; in TGF-β1-intervened HST-T6 cells, the proliferation activity greatly decreased in the miR-122 mimics-transfected group as compared to that in miR-122 negative control-transfected group (P<0.05). Conclusion The miR-122 levels down-regulate in liver fibrosis, and overexpression of it might inhibit the activation and proliferation of hepatic stellate cells, and probably inhibit the occurrence and development of liver fibrosis.
Reference | Related Articles | Metrics
Influencing factors and molecular mechanisms of rifampicin-induced drug-induced liver injury
Xu Shuanghe, Song Shupeng, Li Qian, et al
Journal of Practical Hepatology    2026, 29 (2): 170-174.   DOI: 10.3969/j.issn.1672-5069.2026.02.003
Abstract (165)      PDF(pc) (871KB)(1401)      
Reference | Related Articles | Metrics
Diagnostic efficacy of GD-EOB-DTPA enhanced MRI in differentiation of primary liver cancer from nodular regenerative hyperplasia of liver in patients with hepatitis B cirrhosis
Wang Baofeng, Ma Yangao, Li Yi, et al
Journal of Practical Hepatology    2022, 25 (4): 554-557.   DOI: 10.3969/j.issn.1672-5069.2022.04.025
Abstract (488)      PDF(pc) (3152KB)(1270)      
Objective The aim of this study was to investigate the diagnostic efficacy of GD-EOB-DTPA enhanced magnetic resonance imaging (MRI) in differentiation of primary liver cancer (PLC) fromnodular regenerative hyperplasia of liver (NRH) in patients with hepatitis B cirrhosis. Methods 147 patients with hepatic focal lesions (HFL) in the background of hepatitis B cirrhosis were encountered in our hospital between December 2018 and December 2020, and all patients underwent GD-Eob-DTPA enhanced MRI scan. The foci enhancement characteristics and signal intensity in each sequence were observed, including T1-weighted image (T1WI), T2-weighted image (T2WI), and signal intensity of arterial phase, portal vein phase, hepatobiliary specific phase, and magnetic resonance diffusion weighted imaging (DWI). The area under receiver operating characteristic (ROC) curve (AUC) was applied to analyze the diagnostic efficacy of signal feature. Results Out of our 147 patients with HFL, the contrast-enhanced MRI scan made diagnosis of PLC in 102 cases, with the lesion size of 0.9-2.9 cm (average of 1.8±0.6 cm), and NRH in 45 cases, with lesion size of 0.8-2.5 cm (average of 1.4±0.2 cm); the enhanced MRI scan showed that low or equal enhancement in arterial phase, low enhancement in portal vein phase or in delayed phase in 84 cases, and significant enhancement in arterial stage, without clearance in portal or delayed stage in 63 cases; the proportions of low signal in T1WI, high signal in T2WI, high signal in DWI, increased enhancement in arterial phase, and low signal in hepatobiliary phase in patients with PLC were 50.0%, 79.4%, 82.4%, 52.9%, and 94.1%, significantly higher than 20.0%, 20.0%, 26.7%, 20.0% and 20.0% (P<0.05) in patients with NRH; the ROC analysis showed that the low signal in T1WI (AUC=0.670, sensitivity=0.451), high signal in T2WI (AUC=0.817, sensitivity=0.745), high signal in DWI (AUC=0.754, sensitivity=0.863), high enhancement in arterial phase (AUC=0.693, sensitivity=0.520) and low signal in hepatobiliary phase (AUC=0.891, sensitivity=0.892) had certain diagnostic efficacy for PLC (P<0.05). Conclusion The enhanced MRI scan plays an important role in the diagnosis of PLC under the background of hepatitis B-induced liver cirrhosis.
Reference | Related Articles | Metrics
Diagnostic performance of multimodal MRI in differentiating dysplastic nodules and small hepatocellular carcinoma in patients with liver cirrhosis
Shi Ying, Bai Genji, Sun Yang
Journal of Practical Hepatology    2022, 25 (5): 722-725.   DOI: 10.3969/j.issn.1672-5069.2022.05.029
Abstract (372)      PDF(pc) (1813KB)(2850)      
Objective The aim of this study was to explore the diagnostic performance of multimodal magnetic resonance imaging (MRI) in differentiating dysplastic nodules (DN) and small hepatocellular carcinoma (sHCC) in patients with liver cirrhosis (LC). Methods 71 patients with LC with intrahepatic nodules were encountered in our hospital between December 2016 and December 2021, and all underwent multimodal MRI, with the dynamic enhancement (DCE-MRI) parameters, the apparent diffusion coefficient (ADC), pure diffusion coefficient (D) and pseudo diffusion coefficient (D*) recorded. The golden diagnosis was based on fine needle aspiration or post-operational histopathological examination. Results Among the 71 patients, the sHCC was diagnosed in 45 cases (63.4%), and the DN was found in 26 cases (36.6%); the ADC, D and D * in sHCC foci were (0.81±0.19)×10-3mm2 / s, (0.91±0.21)×10-3mm2 / s and (46.26±10.13)×10-3mm2 / s, significantly lower than [(1.34±0.33)×10-3mm2 / s, (1.22±0.24)×10-3mm2 / s and (80.69±13.24)×10-3mm2/s, respectively, P<0.05 ] in DN lesions; the ROC analysis showed that when the cut-off values of D, D * and ADC in diagnosing sHCC were set as 1.14×10-3mm2 / s, 62.40×10-3mm2 / s and 0.96×10-3mm2/s, the AUC were 0.911 (95% CI: 0.820-0.966), 0.809 (95% CI: 0.699-0.893) and 0.984 (95% CI: 0.920-0.999). Conclusion The multimodal MRI has high diagnostic efficacy in differentiating DN and sHCC in patients with LC, which might provide evidence for appropriate management for the patients.
Reference | Related Articles | Metrics
Comparative analysis on laparoscopic fenestration and ultrasound-guided puncture intervention for the treatment of patients with simple hepatic cyst
Qi Lina, Yan Mei, Guo Jianqin
JOURNAL OF PRACTICAL HEPATOLOGY    2019, 22 (4): 581-584.   DOI: 10.3969/j.issn.1672-5069.2019.04.033
Abstract (403)      PDF(pc) (1030KB)(2479)      
Objective The aim of this study was to compare the efficacies on laparoscopic fenestration and ultrasound-guided puncture intervention for the treatment of patients with simple hepatic cyst (SHC).Methods 94 patients with SHC were recruited in our Department of Interventional Ultrasound and Department of General Surgery between June 2017 and March 2018,and were randomly divided into control group and observation group,with 47 patients in each group. The patients in the control group were treated with laparoscopic fenestration,and those in the observation group were treated with ultrasound-guided puncture intervention. The liver function tests,adverse reactions and total effective rates were observed and compared between the two groups.Results One month after surgery,the total effective rates in both control group and the observation group were 100%;one month after surgery,serum levels of alanine aminotransferase(ALT),aspartate aminotransferase(AST) and total bilirubin (TBIL) in the observation were (28.4±4.3) U/L,(28.5±2.3) U/L and (18.5±2.4) mmol/L,not significantly different as compared to (31.7±4.7) U/L,(31.3±2.4) U/L and (19.9±3.5) mmol/L in the control (P<0.05);after surgery,the incidences of fever,abdominal distension and pain and vomiting in the observation were 14.9%,19.2% and 25.5%,significantly lower than 29.8%,42.6% and 48.9% (P<0.05) in the control. Conclusion The application of ultrasound-guided puncture intervention for the treatment of patients with SHC has the same total effective rate as with laparoscopic fenestration,which might reduce the incidence of adverse reactions,and is worthy for further investigations.
Reference | Related Articles | Metrics
Guidelines on the management of ascites and complications in cirrhosis Chinese Society of Hepatology, Chinese Medical Association
JOURNAL OF PRACTICAL HEPATOLOGY    2018, 21 (1): 21-31.   DOI: 10.3969/j.issn.1672-5069.2018.01.006
Abstract (624)      PDF(pc) (1836KB)(11757)      
Related Articles | Metrics
Combination of Xuezhikang and atorvastatin in treatment of patients with non-alcoholic fatty liver disease and hyperlipidemia
Zheng Huihui, Wang Yurong, Xu Ting
Journal of Practical Hepatology    2025, 28 (6): 834-837.   DOI: 10.3969/j.issn.1672-5069.2025.06.009
Abstract (302)      PDF(pc) (877KB)(2903)      
Objective The aim of this study was to investigate combination of Xuezhikang, a herbal medicine compound, and atorvastatin in treatment of patients with non-alcoholic fatty liver disease (NAFLD) and hyperlipidemia. Methods 124 patients with NAFLD and hyperlipidemia were enrolled in our hospital between January 2022 and July 2024, and were randomly assigned to receive atorvastatin in 63 cases in control, or receive Xuezhikang at base of atorvastatin in another 61 cases in observation for 24 weeks. Fasting insulin was assayed by immunoassay, and HOMA-IR and HOMA-β were calculated. Serum tumor necrosis factor(TNF-α), interleukin -6(IL-6) and IL-8 levels were detected by ELISA. Results By end of 24-week treatment, serum ALT, AST and GGT levels in the observation group were (36.5±3.3)U/L, (32.7±2.8)U/L and (46.4±4.7)U/L, all significantly lower than [(62.8±3.6)U/L, (58.9±3.2)U/L and (64.1±5.3)U/L, respectively, P<0.05] in the control; there were no significant differences as respect to serum TC, TG, LDL-C and HDL-C levels in the two groups (P>0.05); serum FINS and HOMA-IR were (5.3±1.5)μU/ml and (2.7±0.8), both much lower than [(6.4±1.2)μU/ml and (4.1±1.3), respectively, P<0.05], while HOMA-β was (92.3±15.4), much greater than [(77.2±13.7), P<0.05] in the control; serum TNF-α, IL-6 and IL-8 levels were (15.5±6.3)pg/ml, (16.2±5.1)ng/L and (5.5±1.1)μg/L, all significantly lower than [(27.6±6.8)pg/ml, (26.6±5.8)ng/L and (7.2±1.4)μg/L, respectively, P<0.05] in the control group. Conclusion Application of Xuezhikang with combination of atorvastatin in treatment of patients with NAFLD and hyperlipidemia could improve liver function test normal, which might be related to modulation of glycolipid metabolism and inhibition of cytokine reactions.
Reference | Related Articles | Metrics
Polyene phosphatidyl choline and silibinin in treatment of patients with nonalcoholic fatty liver
Liao Wenqiu, Liu Xiaoye,Zhang Li.
JOURNAL OF PRACTICAL HEPATOLOGY    2014, 17 (2): 196-197.   DOI: 10.3969/j.issn.1672-5069.2014.01.024
Abstract (339)      PDF(pc) (286KB)(3201)      
Reference | Related Articles | Metrics
Clinical features and clinical outcomes of patients with anti-tumor drug-induced liver injury
Yan Xinlu, Zhang Lihua, Wang Weiwei, et al
Journal of Practical Hepatology    2026, 29 (2): 229-232.   DOI: 10.3969/j.issn.1672-5069.2026.02.017
Abstract (153)      PDF(pc) (846KB)(1161)      
Objective This study aimed to summarize the clinical features and clinical outcomes of patients with anti-tumor drug-induced liver injury (DILI). Methods A total of 197 patients with anti-tumor DILI were encountered in this study between January and December 2024, and the clinical types were recorded. Clinical outcomes were observed after active liver protection treatment. Results Of the 197 patients with DILI, there were 26 cases of mixed type, 54 cases of cholestasis type and 117 cases of hepatocyte injury type; proportion of anorexia in hepatocyte injury type group was 47.9%, significantly higher than 25.9% in cholestasis type group or 25.0% in mixed type group (P<0.05); serum GGT and ALP levels in hepatocyte injury group were (241.6±79.3)U/L and (99.7±22.8)U/L, both much lower than [(835.2±274.8)U/L and (269.4±78.5)U/L, respectively, P<0.05] in cholestasis type group or [(439.7±145.1)U/L and (203.2±66.9)U/L, respectively, P<0.05] in mixed type group, while serum AST and ALT levels were (382.4±126.7)U/L and (601.9±183.5)U/L, both much higher than [(124.9±41.3)U/L and (109.8±32.7)U/L, respectively, P<0.05] in cholestasis type group or [(140.5±46.2)U/L and (126.4±42.8)U/L, respectively, P<0.05] in mixed type group; percentage of severe liver injury in patients with hepatocyte injury was 29.9%, much lower than 61.1% in patients with cholestasis type or 53.9% in those with mixed injury(P<0.05); liver function tests returned to normal in 175 cases (88.8%) and didn’t in 22 cases (11.2%), and there were no significant differences among liver function recovery rates in the three groups(P>0.05). Conclusion Anti-tumor immune, targeting and chemotherapy might induced DILI easily, and the hepatocyte injury type is very common. The prognosis is usually good with discontinuing anti-tumor medicines in time and active liver protecting treatment.
Reference | Related Articles | Metrics
JOURNAL OF PRACTICAL HEPATOLOGY    2011, 14 (4): 243-245.   DOI: 10.3969/j.issn.1672-5069.2011.04.002
Abstract (252)      PDF(pc) (516KB)(3351)      
Related Articles | Metrics
Clinical implication of peripheral blood T lymphocyte subset changes in patients with syphilis and hepatitis B or hepatitis C coinfection
Qu Xiaowei, Feng Lili, Mao Yanyun
Journal of Practical Hepatology    2022, 25 (1): 34-37.   DOI: 10.3969/j.issn.1672-5069.2022.01.009
Abstract (341)      PDF(pc) (854KB)(2140)      
Objective The aim of this study was to investigate the clinical implication of peripheral blood T lymphocyte subset changes in patients with syphilis and hepatitis B or hepatitis C coinfection. Methods 93 patients with treponema pallidum (TP) syphilis were admitted to our hospital between January 2016 and June 2020, including syphilis infection in 61 cases, syphilis with hepatitis B virus infection in 21 cases and syphilis with hepatitis C virus infection in 11 cases. 84 healthy persons were selected as the control. The peripheral blood T lymphocyte subsets was assayed by FCM. Results The percentages of peripheral blood CD3+, CD4+, CD4+CD45RO+ and CD8+CD45RA+ cells as well as the ratio of CD4+/CD8+ cells in patients with syphilis were(52.2±8.5)%,(40.3±5.7)%,(18.1±3.9)%, (12.4±3.7)% and (1.2±0.3), all significantly lower than [(69.1±7.6)%,(50.7±6.9)%,(20.6±4.7)%,(16.2±4.3)% and (1.9±0.5), respectively, P<0.05], while the percentages of peripheral blood CD8+, CD4+CD45RA+ and CD8+CD45RO+ cells were all significantly higher than those in healthy control [(32.4±7.3)%, (24.7±6.5)% and (8.7±1.5)% vs. (26.2±5.4)%, (21.8±6.2)% and (5.4±1.1)%, respectively, P<0.05]; there were significant differences as respect to the percentages of peripheral blood CD8+, CD4+CD45RA+, CD4+CD45RO+, CD8+CD45RA+, CD8+CD45RO+ cells and the ratio of CD4+/CD8+ cells among patients with TP, with TP and chronic hepatitis B (CHB), and with TP and chronic hepatitis C (CHC, P<0.05), the percentages of CD8+, CD4+CD45RA+ and CD8+CD45RO+ cells in patients with TP and CHB and patients with TP and CHC were all significantly higher than those in patients with TP(P<0.05), while the ratio of CD4+/CD8+ cells, and the percentages of blood CD4+CD45RO+ and CD8+CD45RA+ cells were all significantly lower than those in patients with TP (P<0.05); there were no significant differences respect to the percentage of blood CD8+, CD4+CD45RA+, CD4+CD45RO+, CD8+CD45RA+ and CD8+CD45RO+ cells and the ratio of CD4+/CD8+ cells between patients with TP and CHB, and those with TP and CHC (P>0.05). Conclusion The percentages of peripheral blood CD3+, CD4+, CD8+, CD4+CD45RA+, CD8+CD45RO+, CD4+CD45RO+, CD8+CD45RA+ and the ratio of CD4+/CD8+ cells in patients with TP change greatly, and those in patients with TP and HBV or HCV mixed infection change even significantly, which needs further clinical investigation.
Reference | Related Articles | Metrics
Efficacy and safety of CT-guided percutaneous transhepatic choledochoscopy and dual-frequency laser lithotripsy combination in the treatment of patients with recurrent hepatolithiasis
Wang Ling, Wei Zhili, Song Pinghui
Journal of Practical Hepatology    2022, 25 (1): 108-111.   DOI: 10.3969/j.issn.1672-5069.2022.01.027
Abstract (410)      PDF(pc) (852KB)(1481)      
Objective The aim of this clinical observation was to investigate the efficacy and safety of CT-guided percutaneous transhepatic choledochoscopic lithoteipsy (PTCSL) and dual-frequency laser lithotripsy (DFLL) combination in the treatment of patients with recurrent hepatolithiasis. Methods A total of 60 patients with recurrent hepatolithiasis were admitted to our hospital between September 2017 and February 2020, and 31 patients in group A received CT-guided PTCSL and DFLL and 29 patients in group B underwent open choledochofiberscope and DFLL. Serum cortisol (COR) and epinephrine (EP) were detected. Results The operation time, exhaust time, first defecation time and postoperative hospitalization stay in group A were(89.7±10.1)min, (30.3±3.6)h, (2.3±0.3)d and (6.9±1.1)d, all significantly shorter than [(101.9±12.2)min, (34.7±4.1)h, (2.7±0.4)d and (11.8±1.6)d, respectively, P<0.05], while blood loss was (40.2±8.8)ml, much less than [(97.4±10.6)ml, P<0.05] in group B; at the end of seven days after operation, the white blood cell counts, neutrophil percentage, serum COR and EP levels were (9.7±1.0)×109/L, (67.8±5.9)%, (310.1±30.7)mmol/L and (210.7±22.8)pg/mL, significantly lower than [(11.8±1.3)×109/L, (76.4±7.1)%, (385.5±34.4)mmol/L and (247.3±23.1), respectively, P<0.05] in group B; serum ALT, AST, ALP and bilirubin level were (39.7±3.7)U/L, (39.9±4.1)U/L, (80.1±8.5) and (19.4±1.8)μmol/L, significantly lower than [(45.6±5.1)U/L, (45.5±5.1)U/L, (85.9±6.8) and (23.0±3.4), respectively, P<0.05] in group B; the incidence of postoperative complications was 9.7%, significantly lower than 41.4% (P<0.05) and the stone residual rate was 6.5%, significantly lower than 31.0% in group B(P<0.05). Conclusion CT-guided (PTCSL) and DFLL combination could reduce surgical damage, accelerate postoperative recovery of gastrointestinal functions with low stone residual rate, which might be related to less oxidative stress and inflammatory reaction.
Reference | Related Articles | Metrics
Progress in the diagnosis of drug-induced liver injury
Wang Qingqing, Hu Xiaona, BaoZhijun
JOURNAL OF PRACTICAL HEPATOLOGY    2014, 17 (4): 441-444.   DOI: 10.3969/j.issn.1672-5069.2014.04.032
Abstract (294)      PDF(pc) (831KB)(4025)      
Drug-induced liver injury (DILI) refers to varying degrees of liver damage which caused by the drug itself or its metabolites. In recent years, there has been an increasing number of reports about DILI. However, it is often misdiagnosed for the low incidence of DILI symptoms and lack of specificity. There are various diagnostic criteria of DILI in different countries. So it is of great significance to compare the advantages and disadvantages of these criteria and to find the best diagnostic strategy for early treatment and prognosis of DILI.
Reference | Related Articles | Metrics
Clinical benefits of drug-loaded microsphere transcatheter arterial chemoembolization in treatment of patients with primary liver cancer
Xu Gang, Pan XiaoLin, Wang Ping, et al
Journal of Practical Hepatology    2026, 29 (4): 589-592.   DOI: 10.3969/j.issn.1672-5069.2026.04.028
Abstract (91)      PDF(pc) (1268KB)(808)      
Objective The aim of this study was to explore clinical benefits of drug-loaded microsphere transcatheter arterial chemoembolization (D-TACE) in treatment of patients with primary liver cancer(PLC). Methods 84 patients with PLC were encountered in our hospital between January 2022 and January 2024, and were randomly assigned to underwent D-TACE in 42 cases in observation or underwent conventional TACE in another 42 cases in control. Clinical efficacy was evaluated by mRECIST criteria three months after operation, and objective remission rate (ORR) and disease control rate (DCR) were recorded. All patients were followed-up for one year, and progression-free survival (PFS) and overall survival (OS) were compared. Results There were no significant differences as respect to ORR(54.8% vs. 50.0%) or DCR (97.6% vs. 90.5) between the two groups (P>0.05); by end of one-month after treatment, serum ALT level in the observation was (46.5±8.2)U/L, much lower than [(68.9±11.4)U/L, P<0.05] in the control, while there were no significant differences as respect to serum bilirubin and AFP levels between the two groups (P>0.05); one-year survival rate in the observation was 69.1%, not significant different compared to 59.5% in the control (x2=0.830, P=0.362); either PFS (10.9±0.3) mon, or OS(11.1±0.3)mon, both not significant different as compared to (9.9±0.4) mon(Log-Rank x2=3.287, P=0.070) or (10.0±0.4) mon (Log-Rank x2=3.397, P=0.065) in the control group. Conclusion D-TACE could decrease liver injury in treatment of patients with PLC, and the clinical benefits needs long-term observation.
Reference | Related Articles | Metrics
Clinical efficacy of adenosylmethionine and reduced glutathione in treating patients with drug-induced liver injury
Xiao Lu, Hu Xian, Cai Yingke, et al
Journal of Practical Hepatology    2022, 25 (1): 66-69.   DOI: 10.3969/j.issn.1672-5069.2022.01.017
Abstract (575)      PDF(pc) (847KB)(3259)      
Objective The aim of this study was to observe the clinical efficacy of adenosylmethionine and reduced glutathione in treating patients with drug-induced liver injury (DILI). Methods 90 patients with DILI were enrolled in our hospital between October 2017 and October 2020, and were randomly divided into control and observation group, with 45 cases in each group. The patients in the control group was treated with reduced glutathione, while those in the observation group was additionally treated with adenosylmethionine at base of reduced glutathione. Serum malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) were routinely detected. Results After two to six (3.1±1.4) week treatment, serum ALT, AST and bilirubin levels in the observation group were (61.2±8.3)U/L, (54.5±7.4)U/L and (14.4±4.1)μmol/L, all significantly lower than [(86.5±11.5)U/L, (63.1±8.0)U/L and (21.5±5.4)μmol/L, respectively, P<0.05] in the control; serum prealbumin and cholinesterase levels were (205.5±1.9)mg/L and (5224.1±589.9)u/L, both significantly higher than [(188.5±34.2)mg/L and (4933.9±602.2)u/L, respectively, P<0.05], while serum total bile acids was (7.1±1.7)μmol/L, significantly lower than [(9.5±2.1)μmol/L, P<0.05] in the control; serum MDA level was (4.5±0.7)μmol/L, significantly lower than [(6.5±0.9)μmol/L, P<0.05], while serum SOD and GSH-Px levels were (83.1±7.9)U/L and (125.1±13.7)u/L, both significantly higher than [(75.9±7.2)U/L and (105.5±11.1) u/L, respectively, P<0.05] in the control group. Conclusion The short-term clinical efficacy of adenosylmethionine and reduced glutathione combination in treatment of patients with DILI is good, which could effectively inhibit inflammatory reactions and oxidative stress, and protect the liver functions.
Reference | Related Articles | Metrics
Human serum albumin in combination with lactulose and ornithine aspartate in treatment of patients with liver cirrhosis and hepatic encephalopathy
Xiao Ying, Jin Tao, Jiang Shengjun
Journal of Practical Hepatology    2026, 29 (1): 101-104.   DOI: 10.3969/j.issn.1672-5069.2026.01.026
Abstract (157)      PDF(pc) (833KB)(1514)      
Objective The aim of this study was to observe clinical efficacy of human serum albumin in combination with lactulose and ornithine aspartate in treatment of patients with liver cirrhosis (LC) and hepatic encephalopathy (HE). Methods 58 cirrhotics with complicated HE were enrolled in our hospital between January 2022 and April 2025, and were randomly assigned to receive intravenous human albumin 5 g daily in 28 patients in control, or receive intravenous human albumin 10 g daily in 30 patients in observation. All patients were carefully managed by internal treatment for two weeks. Serum interleukin(IL)-6, IL-8 and C-reactive protein (CRP) levels were detected by ELISA, and HE was evaluated by West Haven scoring system. Results By end of two week observation, three patients (10.7%)died in the control, and one died (3.3%, P>0.05)in the observation groups; total serum bilirubin level in 29 survivals in the observation was (38.2±10.6)μmol/L, much lower than [(50.1±12.7)μmol/L, P>0.05],while serum albumin level was (35.1±2.5)g/L, much higher than [(33.5±2.1)g/L, P<0.05)] in 25 survivals in the control; serumIL-6, IL-8 and CRP levels were (21.2±5.9)pg/mL, (31.4±8.7)pg/mL and(11.5±3.2)mg/L, all significantly lower than [(29.4±6.2)pg/mL, (40.5±10.9)pg/mL and (46.2±4.5)mg/L, respectively, P<0.05] in the control; proportion of West Haven grade 0 in the observation group was 51.7%, much higher than 28.0%(P<0.05) in the control group. Conclusion Human serum albumin infusion in dealing with LC patients with HE could improve regaining consciousness, which might be related to increased plasma colloid osmotic pressure and relatively quick liver functioning.
Reference | Related Articles | Metrics
Comparison of laparoscopic cholecystectomy by through posterior Calot’ s triangle approach or through anterior Calot’ s triangle approach in dealing with patients with cholecystolithiasis and chronic cholecystitis
Zhang Wenjie, Zhou Lichen, Liu Yu, et al
Journal of Practical Hepatology    2025, 28 (5): 784-787.   DOI: 10.3969/j.issn.1672-5069.2025.05.036
Abstract (204)      PDF(pc) (882KB)(1740)      
Objective The purpose of this study was to compare laparoscopic cholecystectomy (LC) by through posterior Calot’ s triangle approach (PCTA) or through anterior Calot’ s triangle approach (ACTA) in dealing with patients with cholecystolithiasis and chronic cholecystitis. Methods 197 patients with cholecystolithiasis and chronic cholecystitis were encountered in our hospital between June 2021 and June 2024, and all underwent LC surgery. For the operation, by through PCTA in 96 cases, and by through ACTA in 101 cases. Visual analogue scale (VAS) was evaluated for postoperative pain. Serum C-reactive protein level was detected by immunoturbidimetry, serum interleukin (IL)-6 and tumor necrosis factor (TNF)-α were detected by ELISA, plasma superoxide dismutase (SOD) level was detected by ammonium phosphate method, plasma glutathione peroxidase (GSH-Px) level was detected by DTNB direct color development, and plasma malondialdehyde (MDA) level was assayed by thiobarbituric acid. Results Surgical time and postoperative exhaust time in PCTA group were(33.6±7.3)min and (22.3±5.6)h, both much shorter than [(39.1±7.1) minand (28.8±6.1)h, respectively, P<0.05], and operational bleeding was (36.9±11.4)mL, much less than [(49.5±12.9)mL, P<0.05] in ACTA group; by end of three days, VAS score in PCTA group was (2.5±0.4)points, much lower than [(3.1±0.5)points, P<0.05] in ACTA group; by 24 h, serum IL-6, IL-8, TNF-α and CRP levels in PCTA group were (12.1±2.0)ng/L, (17.3±2.7)ng/L, (19.5±2.7)ng/L and (18.3±1.6)mg/L, all significantly lower than [(15.2±1.4)ng/L, (22.7±3.1)ng/L, (23.6±3.5)ng/L and (29.1±1.1)mg/L, respectively, P<0.05] in ACTA group; serum SOD level was (121.0±18.4)U/ml, much higher than [(105.3±19.2)U/ml, P<0.05]in ACTA group. Conclusion For LC operation, by through PCTA could be relatively easy, which might cost less operational time and induce less body inflammatory and oxidative stress.
Reference | Related Articles | Metrics
Endocrinologists should pay attention to the outcome of liver diseases in patients with diabetes and non-alcoholic fatty liver diseases
Yu Hongyan, Di Fusheng
JOURNAL OF PRACTICAL HEPATOLOGY    2017, 20 (3): 267-270.   DOI: 10.3969/j.issn.1672-5069.2017.03.004
Abstract (206)      PDF(pc) (425KB)(894)      
Reference | Related Articles | Metrics
Highlight of liver damage in endocrine system diseases
Zhang Siyi, Shi Junping
Journal of Practical Hepatology    2022, 25 (4): 457-459.   DOI: 10.3969/j.issn.1672-5069.2022.04.001
Abstract (410)      PDF(pc) (817KB)(4975)      
Reference | Related Articles | Metrics
Efficacy of small incision of sphincterotomy and balloon dilatation in treatment of patients with juxtapapillary duodenal diverticulum and common bile duct stones
Lu Qing,Liu Xuejun,Woodujutin Aizizi.
JOURNAL OF PRACTICAL HEPATOLOGY    2017, 20 (5): 592-595.   DOI: 10.3969/j.issn.1672-5069.2017.05.021
Abstract (368)      PDF(pc) (678KB)(885)      
Objective To investigate the efficacy of small incision of endoscopic sphincterotomy (SEST) and endoscopic papillary balloon dilatatio (EPBD) in treatment of patients with juxtapapillary duodenal diverticulum(JPDD) and common bile duct stones. Methods 82 patients with choledocholithiasis of JPDD were divided into study group and control group, with 41 cases in each group. The patients in the control group were treated with EST and in the study group were treated with SEST and EPBD. Results The one time success rate (90.24%) and the total success rate(95.12%) in the study group were higher than those in the control group (73.17% and 78.05%,respectively),and the mechanical lithotripsy rate was 12.20%,much lower than 31.71% in the control group (P<0.05);the hospitalization stay in the study group was (7.98±1.14) days,much shorter than (11.03±1.39) days in the control group(P<0.05);serum bilirubin levels in the two groups before and after operation had no significant difference (P>0.05);The incidence rates of complications(9.76%) in the study group was lower than (36.59%) in the control group(P<0.05). Conclusion Small endoscopic sphincterotomy and balloon dilation in the treatment of patients with juxtapapillary duodenal diverticulum accompanied by common bile duct stones has a good efficacy,with higher success rate of stone removal, shorter hospitalization stay,and lower incidence rate of complications.
Reference | Related Articles | Metrics
Prevalence of serum autoantibody spectrums in patients with different liver diseases
Sun Cui, Cao Linlin, Liu Jun
Journal of Practical Hepatology    2023, 26 (3): 368-371.   DOI: 10.3969/j.issn.1672-5069.2023.03.017
Abstract (376)      PDF(pc) (810KB)(1891)      
Objective The aim of this study was to investigate the prevalence of serum autoantibody spectrums in patients with different liver diseases. Methods 92 patients with autoimmune liver diseases (ALD), including autoimmune hepatitis (AIH) in51 cases, primary biliary cholangitis (PBC) in 27 cases and primary sclerosing cholangitis (PSC) in 14 cases, chronic hepatitis B(CHB) in 61 cases and chronic hepatitis C (CHC) in 15 cases, nonalcoholic steatohepatitis (NASH) in 34 cases, drug-induced liver injury (DILI) in 27 cases and healthy persons in 68 cases were recruited in our hospital between March 2019 and March 2022, and serum autoimmune antibody spectrum was detected by immunoblotting. Results The positive rates of anti-mitochondrial antibody M2 subtype (AMA-M2), anti-soluble liver antigen/anti-liver pancreas antibody (SLA/LP), anti-liver kidney microsomal antibody type I (LKM-1), anti-transmembrane glycoprotein 210 (gp210), anti-liver cytosol antigen type I (LC-1), anti-3E, anti-promyelocytic leukemia (PML) and anti-RO-52 in patients with ALD 23.9%,13.0%,33.7%,19.6%,26.1%, 33.7%, 23.9% and 55.4%, significantly higher than in patients with other liver diseases (P<0.05); the positive rates of anti-SLA/LP, anti-LKM-1 and anti-LC-1 in patients with AIH were much higher than in patients with PBC or in patients with PSC(P<0.05), while the positive rates of AMA-M2, anti-gp210 and anti-3E in patients with PBC were much higher than in patients with AIH or in those with PSC(P<0.05); the positive rates of serum anti-LKM-1 and anti-LC-1 in 24 patients with AIH type Ⅱ were 100.0% and 66.7%, much higher than 19.0% and 19.0% (P<0.05) in 21 patients with AIH type Ⅰ or 16.7% and 33.3% (P<0.05) in 6 patients with AIH type Ⅲ, while the positive rate of serum anti-SLA/LP in patients with AIH type Ⅲ was 83.3%, much higher than 9.5% in patients with AIH type Ⅰ or 16.7% in patients with AIH type Ⅱ(P<0.05). Conclusion The detection of serum autoantibody spectrums is a key approach for the diagnosis and clinical classification of patients with ALD, and why they appear, though at low prevalence, in patients with other liver diseases needs further investigation.
Reference | Related Articles | Metrics